Tuesday, 16 July 2019
Latest news
Main » Stifel Nicolaus Analysts Give DCP Midstream Partners (DCP) a $43.00 Price Target

Stifel Nicolaus Analysts Give DCP Midstream Partners (DCP) a $43.00 Price Target

08 April 2018

As per Tuesday, January 16, the company rating was maintained by RBC Capital Markets. The firm has a market capitalization of $5,024.44, a price-to-earnings ratio of 57.47 and a beta of 2.09.

NYSE:DCP traded down $0.52 during midday trading on Monday, reaching $34.88. About 3.58M shares traded. It has underperformed by 15.30% the S&P500. Goldman Sachs raised shares of DCP Midstream Partners from a "sell" rating to a "neutral" rating and set a $48.00 target price for the company in a research note on Thursday, February 1st. They expect $0.32 EPS, down 21.95 % or $0.09 from last year's $0.41 per share. The fund owned 10,775 shares of the company's stock after selling 898 shares during the period.

The stock increased 0.00% or $0.4 during the last trading session, reaching $37.6. Yorkville Capital Mgmt Ltd Liability has 0.98% invested in DCP MIDSTREAM LP (NYSE:DPM) for 22,374 shs. The stock underperformed the S&P500 by 11.55%. Wunderlich lifted their price objective on DCP Midstream Partners, from $35.00 to $36.00 and gave the stock a "buy" rating in a research report on Wednesday, August 31st.

Wells Fargo & Company MN raised its holdings in DCP Midstream Partners (NYSE:DCP) by 132.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. As per Thursday, November 9, the company rating was maintained by Stifel Nicolaus. The rating was maintained by UBS on Friday, March 2 with "Buy". The stock has "Neutral" rating by Citigroup on Wednesday, January 18. Bank of America started coverage on DCP Midstream Partners in a report on Tuesday, January 9th.

Investors sentiment decreased to 1.01 in 2017 Q4. Its down 0.07, from 1.08 in 2017Q3. The ratio improved due to DPM positioning: 16 sold and 41 reduced. After $0.10 actual earnings per share reported by DCP Midstream, LP for the previous quarter, Wall Street now forecasts 220.00 % EPS growth. Registered Advisor Inc has 12,400 shares for 0.21% of their portfolio. 958.76 million shares or 0.63% less from 964.87 million shares in 2017Q3 were reported. Barclays Public Limited accumulated 0% or 60,613 shares. Wedge Cap Mgmt L LP Nc has 0% invested in PepsiCo, Inc. DCP's profit will be $46.80M for 27.25 P/E if the $0.32 EPS becomes a reality. Blair William Il reported 0.01% in DCP MIDSTREAM LP (NYSE:DPM). Heronetta Management L.P., a New York-based fund reported 132,800 shares. Texas Yale Capital holds 42,050 shares. Metropolitan Life Insur Company Ny holds 0.1% or 214,696 shs in its capital. The Mufg Americas Holdings Corp holds 28,743 shares with $2.13 million value, up from 17,425 last quarter. Dodge And Cox reported 15.42M shares. Arrowstreet Ltd Partnership has 3.07M shares. (NASDAQ:PEP). Bb&T Secs Llc holds 0.75% or 483,438 shares in its portfolio. Bessemer Gp Inc reported 1,095 shares. (NASDAQ:GILD). Canandaigua National Bank & Trust & accumulated 32,650 shares. Regentatlantic Ltd has 58,072 shares for 0.34% of their portfolio. Jefferies maintained Corium International, Inc. Ftb Advsr Incorporated stated it has 0.51% in Gilead Sciences, Inc. Northern holds 68,168 shs or 0% of its capital. Mcgowan Grp Inc Asset Mngmt reported 159,997 shs. Renaissance Tech Ltd Liability Com holds 0.6% or 7.56 million shares. MEAGHER LAURA C sold $990,549 worth of stock. Washington Robin L sold $401,566 worth of stock or 5,000 shares. The company was upgraded on Thursday, January 5 by Stifel Nicolaus. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company's stock. Macquarie Research has "Outperform" rating and $90 target. The stock of DCP Midstream, LP (NYSE:DCP) earned "Hold" rating by RBC Capital Markets on Wednesday, February 14. Morgan Stanley maintained Gilead Sciences, Inc.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.